CMV infected or not CMV infected: That is the question

Cytomegalovirus (CMV) infection is widespread in the human population. Normally, in adolescents and adults, prior exposure to CMV can readily be determined by IgG assays. However, in individuals where antibody production is impaired, such as patients with common variable immunodeficiency disease or in the very young where maternal antibodies are present, diagnosis of CMV infection is problematic using such assays. In this issue of the European Journal of Immunology, a study by Sester and colleagues [Eur J Immunol 2013. 43: 1099‐1108] using CD4+ T‐cell immunity as a marker of infection clearly differentiates young children with prior exposure to CMV from those who only have passive maternal antibody. This information will quickly find application in the pretransplant screening of young children for CMV infection and help with the stratification of these children to identify those who are truly CMV negative and are therefore at risk for future CMV infection and disease if receiving an organ from a CMV‐positive donor as discussed in this Commentary.

[1]  L. Gortner,et al.  Cytomegalovirus‐specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies , 2013, European journal of immunology.

[2]  A. Muntasell,et al.  Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK‐cell subset distribution in children , 2012, European journal of immunology.

[3]  L. E. Pedersen,et al.  Immune markers and correlates of protection for vaccine induced immune responses. , 2012, Vaccine.

[4]  V. Emery,et al.  Cytomegalovirus: recent progress in understanding pathogenesis and control. , 2012, QJM : monthly journal of the Association of Physicians.

[5]  V. Emery,et al.  Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. , 2012, The Journal of allergy and clinical immunology.

[6]  R. Vandlen,et al.  Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin , 2012, Journal of Virology.

[7]  P. Klenerman,et al.  Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. , 2011, The Journal of allergy and clinical immunology.

[8]  Antonio Lanzavecchia,et al.  Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex , 2009, Journal of Virology.

[9]  V. Emery,et al.  Cytomegalovirus in transplantation – challenging the status quo , 2007, Clinical transplantation.

[10]  V. Emery,et al.  The T cell response to persistent herpes virus infections in common variable immunodeficiency , 2006, Clinical and experimental immunology.

[11]  Louis J. Picker,et al.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.

[12]  M. Girndt,et al.  Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity1 , 2003, Transplantation.

[13]  P. Griffiths,et al.  Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. , 1999, The Journal of infectious diseases.

[14]  Vincent C. Emery,et al.  The Dynamics of Human Cytomegalovirus Replication in Vivo , 1999, The Journal of experimental medicine.

[15]  P. Klenerman,et al.  Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers , 2001, Reviews in medical virology.

[16]  W. Britt,et al.  Human cytomegalovirus glycoproteins. , 1996, Intervirology.